Veljanov, Z. and Fazekas, M. (2023). Efficiency gains from anti-corruption in pharmaceuticals procurement: Analysis of 9 countries across 3 continents. GTI-WP/2023:04, Budapest: Government Transparency Institute.
Public procurement of pharmaceutical products represents a large share of countries’ health care spending. The crucial importance of pharmaceutical products has been further exposed by the COVID-19 pandemic. Inefficiencies and corruption risks in public spending on the procurement of pharmaceuticals increase medical costs and place a heavy burden on national budgets and patients.
To support …